Pizotifen is a potent serotonin and tryptamine antagonist used in research for migraine prophylaxis, as evidenced by its role in Sandomigran. Its additional weak anticholinergic, antihistaminic, and sedative properties make it a compound of interest for in vitro receptor binding studies and in vivo models of headache and appetite regulation.
